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INTRODUCTION 71
It is well-documented that recovery from exercise is associated with a disturbance in thermal 72
homeostasis. This response is characterized by a marked and rapid suppression of heat loss 73 responses (i.e., sweating and cutaneous blood flow) within ~20 min following exercise cessation 74 despite persistent elevations in core and muscle temperatures for up to 90 min postexercise (19, 75 20, 22, 34, 37) . The body's compromised ability to dissipate heat postexercise has been 76 attributed to the actions of nonthermal factors (21). In fact, numerous studies in the past decade 77 have demonstrated that nonthermal factors (e.g., baroreceptors, muscle mechano-78 /metaboreceptors) have a pivotal role in the modulation of postexercise heat loss and therefore 79 core temperature regulation (8, 15, 17, 18, 22, 28, 29) . A number of these studies have alluded to 80 the hypothesis that baroreceptor activity associated with postexercise hypotension, characterized 81 by a marked reduction in blood pressure from pre-exercise levels lasting ~2 h (13), is primarily 82 responsible for mediating the attenuation of postexercise heat loss. However, recent evidence 83
indicates that there may be interplay between nonthermal baroreceptors and metaboreceptors in 84 their modulation of postexercise heat loss (28). 85
McGinn and colleagues (28) were the first to demonstrate that briefly stimulating the 86 metaboreceptors during postexercise recovery can evoke a transient increase in sweating and 87 reduction in cutaneous vascular conductance (CVC). The authors used a classic model to study 88 the metaboreflex whereby isometric handgrip (IHG) exercise was followed by forearm ischemia 89 to trap the metabolites, resulting in a concomitant increase in mean arterial pressure (MAP) 90 (indicating that the metaboreceptors have been activated) (35). Moreover, an acute application of 91 lower body negative pressure (LBNP) was employed during forearm ischemia to reverse the 92 acute reflex increase in MAP such that the effect of the metaboreflex was assessed in the absence 93 Metabo-and baroreflex modulation of postexercise heat loss On the day of the experimental sessions, participants reported to the laboratory after 144 eating a light meal and drinking 500 mL of water no less than 2 h before their arrival. Upon 145 arrival, participants provided a urine sample and voided the remainder of their bladder before 146 weighing themselves nude using a digital weight scale platform (Model CBU150X, Mettler 147
Toledo, Scherzenbach, Switzerland) with a weighing terminal (Model IND560, Mettler Toledo). 148
Thereafter participants' body height was measured using a stadiometer. 149
Participants performed two brief (<3 s) maximal voluntary contractions with the right 150 hand using a handgrip dynamometer. The higher of the two maximal voluntary contractions was 151 used to determine the relative workload for the isometric handgrip (IHG) exercise (60% of 152 maximal voluntary contraction, average workload: 30 ± 2 kg). Thereafter, participants were 153 instrumented with sweat capsules (~20 min) in a thermoneutral room outside an environmental 154 chamber (Can-Trol Environmental Systems, Markham, ON, Canada) such that sweating was 155 avoided for proper adhesion of the capsules. The remainder of the instrumentation period took 156 place inside the environmental chamber regulated at 35°C and 20% relative humidity with 157 participants seated upright (~60 min). 158
After a 10-min baseline resting period, participants performed the metaboreceptor 159 activation protocol. This consisted of 1 min of IHG exercise at 60% maximal voluntary 160 contraction (as verified by visual feedback) immediately followed by a 2-min occlusion of blood 161 flow to the arm (forearm ischemia) after which participants recovered for 2 min. For the 162 occlusion, a pressure cuff was inflated to suprasystolic levels (>240 mmHg) and was rapidly 163 deflated for the recovery period. Participants were then required to perform 15 min of treadmill 164 running at >90% of maximal heart rate (average heart rate across participants: 182 ± 1 bpm). 165
After treadmill exercise, participants were immediately transferred (~5 min) to an upright seated8 Metabo-and baroreflex modulation of postexercise heat loss pressure box sealed at the iliac crests with custom-made neoprene shorts. Thereafter participants 167 remained seated for an additional 8 min to allow for a brief undisturbed natural recovery. This 168 ensured that the thermal and cardiovascular responses returned to similar levels in each condition 169 prior to pressure application. The metaboreceptor activation protocol was then repeated at 15, 30, 170 45 and 60 min of recovery (i.e., R15, R30, R45, and R60, respectively). On separate days, either 171 LBPP (+40 mmHg), LBNP (-20 mmHg), or no pressure (0 mmHg with circulating air to 172 standardize this effect across conditions, Control) was applied continuously starting at 13 min of 173 recovery and lasting for the duration of the 65-min recovery period. Given that previous studies 174
showed marked changes in baroreceptor loading status within 2 min of pressure application (3, 175 28), we selected the 13-min time point of recovery to initiate changes in baroreceptor loading 176 status (i.e., application of LBNP, LBPP or no pressure) to ensure that the acute responses to 177 altered baroreflex activity passed before the first assessment of metaboreceptor activation at 15 178 min of recovery (i.e., R15). Finally, at the end of the experimental session, peak cutaneous blood 179 flow was determined by local heating at the measurement sites to 42°C for ~10 min followed by 180 an additional ~20 min at a temperature of 44°C until a plateau was observed for at least 2-3 min. 181
Measurements. Esophageal temperature was measured continuously using a general 182 purpose thermocouple temperature probe (Mallinckrodt Medical Inc., St-Louis, MO, USA) ~2 183 mm in diameter that was inserted ~40 cm past the nostril and into the esophagus while the 184 participants sipped 100-300 mL of water through a straw. Skin temperatures were measured at 185 six skin sites using thermocouples (Concept Engineering, Old Saybrook, CT, USA) attached 186 with surgical tape. Mean skin temperature was calculated using 6 skin temperatures weighted to 187 the regional proportions as determined by Hardy & Dubois (14): upper back 21%, chest 21%, 188 quadriceps 9.5%, hamstrings 9.5%, front calf 20%, and biceps 19%. All temperature data were Esophageal and mean skin temperatures were analyzed using a 2R-ANOVA with the factors of 251 time (five levels) and pressure condition (three levels). A 2R-ANOVA with the factors of time 252 (two levels: pre-and post-trial) and pressure condition (three levels) was performed for urine 253 specific gravity. To verify that a similar intensity was achieved in the experimental sessions for 254 IHG exercise and treadmill running exercise, a 1R-ANOVA with the factor of pressure condition 255 (three levels) was performed for maximal voluntary contraction and for end treadmill running 256 exercise heart rate, respectively. A 1R-ANOVA was also performed for CVC, absolute local 257 sweat rate, MAP, and heart rate measured at 10 min postexercise to verify that similar 258 Metabo-and baroreflex modulation of postexercise heat loss thermoeffector activity levels were achieved between conditions prior to pressure treatment. Pre-259 session body mass was assessed using a 1R-ANOVA with the factor of pressure condition (three 260 levels). When a significant interaction or main effect was observed, post-hoc comparisons were 261 carried out using paired samples t tests. For all analyses, differences were considered significant 262 when P ≤ 0.05. All statistical analyses were performed using the statistical software package 263 SPSS 22.0 for Windows (SPSS Inc. Chicago, IL). Finally, it should be noted that the three-way 264 ANOVA used in our study has a relatively increased potential for type II error. As our aim was 265 to simultaneously assess the effects of pressure condition, recovery time, and metaboreceptor 266 protocol stage, this method was the most appropriate to achieve the set objectives. 267
RESULTS 268
Hydration status and Exercise intensity 269
Hydration status, as assessed by pre-nude body mass, was similar between conditions (Control, 270 74.98 ± 2.27; LBPP, 74.91 ± 2.19; and LBNP, 74.66 ± 2.29 kg, P = 0.44). Urine specific gravity 271 was increased from the start (Control, 1.009 ± 0.002; LBPP, 1.011 ± 0.002; LBNP, 272
1.008 ± 0.002) to the end (Control, 1.016 ± 0.001; LBPP, 1.017 ± 0.001; LBNP, 1.019 ± 0.002) 273 of the experimental sessions (P < 0.01). The maximal voluntary contraction used to determine 274 IHG exercise intensity (Control, 50 ± 2; LBPP, 51 ± 3; LBNP, 51 ± 3 kg, P = 0.51) as well as 275 end-treadmill running exercise heart rate (Control, 184 ± 2; LBPP, 182 ± 1; LBNP, 181 ± 2 bpm, 276 P = 0.08) did not differ between pressure conditions. 277 278
Temperature responses 279
Esophageal temperature. An interaction of pressure condition and time was detected for 280 esophageal temperature (P < 0.01, Table 1 ). Specifically, esophageal temperature was similar 281 between conditions from baseline until 15 min postexercise inclusively (all P ≥ 0.14). During 282 LBNP, esophageal temperature was greater compared to Control at 30, 45, and 60 min 283 postexercise (P ≤ 0.05) whereas it decreased more rapidly with LBPP compared to Control from 284 45 min postexercise until the end of the session (all P ≤ 0.01). 285
Mean skin temperature. An interaction of pressure condition and time was observed for 286 mean skin temperature (P < 0.01, Table 1 ). During LBPP application, mean skin temperature 287 was similar to Control throughout the experimental session (all P ≥ 0.25). In contrast, while 288 mean skin temperature did not differ between LBNP and Control up to 30 min postexercise 289 Metabo-and baroreflex modulation of postexercise heat loss (all P ≥ 0.24), a reduction in mean skin temperature was noted during LBNP relative to Control 290 by 0.39 ± 0.13 and 0.43 ± 0.14°C at 45 and 60 min postexercise respectively (both P ≤ 0.01). 291
292
Cardiovascular responses 293
Heart rate. Heart rate exhibited an interaction of pressure condition and time (P < 0.01, Fig. 1A ) 294 such that while it was similar between conditions during baseline resting (all P ≥ 0.08), heart rate 295 gradually decreased during LBPP by 13 ± 3 bpm more than Control by 60 min of recovery 296 (P < 0.01, Table 2 ). Conversely, the application of LBNP resulted in a heart rate greater than 297
Control by 9 ± 3 bpm by 60 min postexercise (P < 0.01). In addition, heart rate increased during 298 each IHG exercise relative to pre-IHG levels in all conditions (all P ≤ 0.01). Although heart rate 299 decreased below pre-IHG levels with forearm ischemia during baseline metaboreceptor protocol 300 in all conditions (P ≤ 0.04), we did not observe this response in the four metaboreceptor 301 protocols performed in the postexercise recovery period under LBNP. 302
MAP. An interaction of pressure condition and time was detected for MAP (P < 0.01, 303 ; all 324 P ≤ 0.01; Fig. 2 ). During R15, while sweat rate was increased from resting levels during IHG 325 exercise for LBPP and LBNP (P < 0.05), it was not different during forearm ischemia in any 326 condition (P ≥ 0.12). Conversely, at R30, R45 and R60, sweat rate was increased during IHG 327 exercise from resting levels and remained elevated with forearm ischemia (all P < 0.01). 328 Importantly, the magnitude of this response (i.e., ∆sweat rate) was similar to that observed at 329 baseline resting (all P ≥ 0.14). 330
Sweating -Skin sites. An interaction of time and skin site (P = 0.001) was detected for 331 absolute local sweat rate. Specifically, at pre-IHG resting of each metaboreceptor protocol, 332 forearm sweating was lower compared to the chest and upper back (P ≤ 0.05), while the latter 333 two sites exhibited similar levels of sweating (P ≥ 0.05; Fig. 3A, B, C) . Additionally, ∆sweat rate 334 during forearm ischemia did not differ between skin sites at any time (all P > 0.05; were observed postexercise such that LBNP application was associated with reduced forearm 338 and upper back CVC relative to LBPP and Control at 30-60 min postexercise (all P < 0.05, Table  339 2). On the other hand, CVC during LBPP application was similar to Control (all P ≥ 0.16). 340
CVC -Effect of metaboreceptor activation. During the baseline resting metaboreceptor 341
protocol, forearm CVC was increased from pre-IHG levels during IHG exercise for LBPP and 342 LBNP only (P ≤ 0.05), whereas CVC did not differ from pre-IHG levels with forearm ischemia 343 in any condition (all P ≥ 0.12; recently reported that forearm ischemia in the absence of a preceding IHG exercise bout in the 376 postexercise period maintained an elevated sweat rate (i.e., sweat rate did not increase further) 377 Metabo-and baroreflex modulation of postexercise heat loss rather than rapidly decreasing as was reported in a separate condition whereby no IHG exercise 378 or forearm ischemia were employed. In this case, it was argued that metaboreceptors still 379 modulated sweating through a transient delay in the suppression of postexercise sweating 380 towards baseline levels. Likewise, we did not detect a metaboreflex-induced increase in sweating 381 during forearm ischemia at 15 min postexercise in our study; however, it appears that 382 metaboreceptor activation prevented a further decrease in sweat rate (Figure 3 
